, Volume 66, Issue 10, pp 1339–1350 | Cite as

Experience with Remifentanil in Neonates and Infants

  • Lars WelzingEmail author
  • Bernhard Roth
Review Article


Remifentanil is a relatively new synthetic opioid, which is not licensed worldwide for neonates and infants. Because of its unique pharmacokinetic properties with a short recovery profile, it could be the ideal opioid for neonates and infants, who are especially sensitive to respiratory depression by opioids. Therefore, we conducted a MEDLINE search on all articles dealing with the use of remifentanil in this important subgroup of patients. Most experience with remifentanil in neonates and infants is as maintenance anaesthesia during surgery. In approximately 300 neonates and infants, remifentanil proved to be an effective and safely used opioid for this indication. However, very limited data exist on remifentanil for analgesia and sedation of mechanically ventilated paediatric intensive care patients. Further research with remifentanil in neonates and infants should focus on this group of patients because remifentanil, with its very short context-sensitive half-life, could result in shorter extubation times compared with commonly used opioids such as morphine or fentanyl.


Sevoflurane Remifentanil Sufentanil Alfentanil Remifentanil Infusion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Anand KJ, Scalzo FM. Can adverse neonatal experiences alter brain development and subsequent behavior? Biol Neonate 2000; 77(2): 69–82PubMedCrossRefGoogle Scholar
  2. 2.
    Buskila D, Neumann L, Zmora E, et al. Pain sensitivity in prematurely born adolescents. Arch Pediatr Adolesc Med 2003; 157(11): 1079–82PubMedCrossRefGoogle Scholar
  3. 3.
    Lidow MS. Long-term effects of neonatal pain on nociceptive systems. Pain 2002; 99(3): 377–83PubMedCrossRefGoogle Scholar
  4. 4.
    Stevens B, McGrath P, Gibbins S, et al. Procedural pain in newborns at risk for neurologic impairment. Pain 2003; 105(1–2): 27–35PubMedCrossRefGoogle Scholar
  5. 5.
    Banos JE, Barajas C, Martin ML, et al. A survey of postoperative pain treatment in children of 3–14 years. Eur J Pain 1999; 3(3): 275–82PubMedCrossRefGoogle Scholar
  6. 6.
    Bremerich DH, Neidhart G, Roth B, et al. Postoperative pain therapy in pediatrics: results of a representative survey in Germany [in German]. Anaesthesist 2001; 50(2): 102–12PubMedCrossRefGoogle Scholar
  7. 7.
    Johr M. Postoperative pain therapy in children [in German]. Schmerz 2000; 14(1): 45–55PubMedCrossRefGoogle Scholar
  8. 8.
    Sittl R, Griessinger N, Koppert W, etal. Management of postoperative pain in children [in German]. Schmerz 2000; 14(5): 333–9PubMedCrossRefGoogle Scholar
  9. 9.
    Egan TD, Lemmens HJ, Fiset P, et al. The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers. Anesthesiology 1993; 79(5): 881–92PubMedCrossRefGoogle Scholar
  10. 10.
    Glass PS, Hardman D, Kamiyama Y, et al. Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: remifentanil (GI87084B). Anesth Analg 1993; 77(5): 1031–40PubMedCrossRefGoogle Scholar
  11. 11.
    Dershwitz M, Hoke JF, Rosow CE, et al. Pharmacokinetics and pharmacodynamics of remifentanil in volunteer subjects with severe liver disease. Anesthesiology 1996; 84(4): 812–20PubMedCrossRefGoogle Scholar
  12. 12.
    Hoke JF, Shlugman D, Dershwitz M, et al. Pharmacokinetics and pharmacodynamics of remifentanil in persons with renal failure compared with healthy volunteers. Anesthesiology 1997; 87(3): 533–41PubMedCrossRefGoogle Scholar
  13. 13.
    Scott LJ, Perry CM. Remifentanil: a review of its use during the induction and maintenance of general anaesthesia. Drugs 2005; 65(13): 1793–823PubMedCrossRefGoogle Scholar
  14. 14.
    Katz R, Kelly HW. Pharmacokinetics of continuous infusions of fentanyl in critically ill children. Crit Care Med 1993; 21(7): 995–1000PubMedCrossRefGoogle Scholar
  15. 15.
    Koehntop DE, Rodman JH, Brundage DM, et al. Pharmacokinetics of fentanyl in neonates. Anesth Analg 1986; 65(3): 227–32PubMedCrossRefGoogle Scholar
  16. 16.
    Latasch L, Freye E. Pain and opioids in preterm and newborns [in German]. Anaesthesist 2002; 51(4): 272–84PubMedCrossRefGoogle Scholar
  17. 17.
    Egan TD. Remifentanil pharmacokinetics and pharmacodynamics: a preliminary appraisal. Clin Pharmacokinet 1995; 29(2): 80–94PubMedCrossRefGoogle Scholar
  18. 18.
    Wilhelm W, Wrobel M, Kreuer S, et al. Remifentanil: an update [in German]. Anaesthesist 2003; 52(6): 473–94PubMedGoogle Scholar
  19. 19.
    Davis PJ, Ross AK, Henson LG, et al. Remifentanil pharmacokinetics in neonates [abstract]. Anesthesiology 1997; 87(3A): A1064CrossRefGoogle Scholar
  20. 20.
    Davis PJ, Wilson AS, Siewers RD, et al. The effects of cardiopulmonary bypass on remifentanil kinetics in children undergoing atrial septal defect repair. Anesth Analg 1999; 89(4): 904–8PubMedGoogle Scholar
  21. 21.
    Kearns GL, Abdel-Rahman SM, Alander SW, et al. Developmental pharmacology: drug disposition, action, and therapy in infants and children. N Engl J Med 2003; 349(12): 1157–67PubMedCrossRefGoogle Scholar
  22. 22.
    Ross AK, Davis PJ, Dear Gd GL, et al. Pharmacokinetics of remifentanil in anesthetized pediatric patients undergoing elective surgery or diagnostic procedures. Anesth Analg 2001; 93(6): 1393–401PubMedCrossRefGoogle Scholar
  23. 23.
    James MK, Feldman PL, Schuster SV, et al. Opioid receptor activity of GI 87084B, a novel ultra-short acting analgesic, in isolated tissues. J Pharmacol Exp Ther 1991; 259(2): 712–8PubMedGoogle Scholar
  24. 24.
    James MK, Vuong A, Grizzle MK, et al. Hemodynamic effects of GI 87084B, an ultra-short acting mu-opioid analgesic, in anesthetized dogs. J Pharmacol Exp Ther 1992; 263(1): 84–91PubMedGoogle Scholar
  25. 25.
    Patel SS, Spencer CM. Remifentanil. Drugs 1996; 52(3): 417–27PubMedCrossRefGoogle Scholar
  26. 26.
    Glass PS, Gan TJ, Howell S. A review of the pharmacokinetics and pharmacodynamics of remifentanil. Anesth Analg 1999; 89 (4 Suppl.): S7–14PubMedCrossRefGoogle Scholar
  27. 27.
    Davis PJ, Finkel JC, Orr RJ, et al. A randomized, double-blinded study of remifentanil versus fentanyl for tonsillectomy and adenoidectomy surgery in pediatric ambulatory surgical patients. Anesth Analg 2000; 90(4): 863–71PubMedCrossRefGoogle Scholar
  28. 28.
    Ganidagli S, Cengiz M, Baysal Z. Remifentanil vs alfentanil in the total intravenous anaesthesia for paediatric abdominal surgery. Paediatr Anaesth 2003; 13(8): 695–700PubMedCrossRefGoogle Scholar
  29. 29.
    Prys-Roberts C, Lerman J, Murat I, et al. Comparison of remifentanil versus regional anaesthesia in children anaesthetised with isoflurane/nitrous oxide. International Remifentanil Paediatric Anaesthesia Study group. Anaesthesia 2000; 55(9): 870–6Google Scholar
  30. 30.
    Weale NK, Rogers CA, Cooper R, et al. Effect of remifentanil infusion rate on stress response to the pre-bypass phase of paediatric cardiac surgery. Br J Anaesth 2004; 92(2): 187–94PubMedCrossRefGoogle Scholar
  31. 31.
    Chanavaz C, Tirel O, Wodey E, et al. Haemodynamic effects of remifentanil in children with and without intravenous atropine: an echocardiographic study. Br J Anaesth 2005; 94(1): 74–9PubMedCrossRefGoogle Scholar
  32. 32.
    Tirel O, Chanavaz C, Bansard JY, et al. Effect of remifentanil with and without atropine on heart rate variability and RR interval in children. Anaesthesia 2005; 60(10): 982–9PubMedCrossRefGoogle Scholar
  33. 33.
    Amin HM, Sopchak AM, Esposito BF, et al. Naloxone-induced and spontaneous reversal of depressed ventilatory responses to hypoxia during and after continuous infusion of remifentanil or alfentanil. J Pharmacol Exp Ther 1995; 274(1): 34–9PubMedGoogle Scholar
  34. 34.
    Davis PJ, Galinkin J, McGowan FX, et al. A randomized multicenter study of remifentanil compared with halothane in neonates and infants undergoing pyloromyotomy: I. Emergence and recovery profiles. Anesth Analg 2001; 93(6): 1380–6Google Scholar
  35. 35.
    Galinkin JL, Davis PJ, McGowan FX, et al. A randomized multicenter study of remifentanil compared with halothane in neonates and infants undergoing pyloromyotomy: II. Perioperative breathing patterns in neonates and infants with pyloric stenosis. Anesth Analg 2001; 93(6): 1387–92Google Scholar
  36. 36.
    Wee LH, Moriarty A, Cranston A, et al. Remifentanil infusion for major abdominal surgery in small infants. Paediatr Anaesth 1999; 9(5): 415–8PubMedCrossRefGoogle Scholar
  37. 37.
    Schmidt J, Fechner J, Fritsch B, et al. Propofol-remifentanil versus sevoflurane-remifentanil for anesthesia for pediatric procedures in infants, children and adolescents [in German]. Anaesthesist 2001; 50(10): 757–66PubMedCrossRefGoogle Scholar
  38. 38.
    Bell G, Dickson U, Arana A, et al. Remifentanil vs fentanyl/ morphine for pain and stress control during pediatric cardiac surgery. Paediatr Anaesth 2004; 14(10): 856–60PubMedCrossRefGoogle Scholar
  39. 39.
    Akpek EA, Erkaya C, Donmez A, et al. Remifentanil use in children undergoing congenital heart surgery for left-to-right shunt lesions. J Cardiothorac Vasc Anesth 2005; 19(1): 60–6PubMedCrossRefGoogle Scholar
  40. 40.
    Roulleau P, Gall O, Desjeux L, et al. Remifentanil infusion for cleft palate surgery in young infants. Paediatr Anaesth 2003; 13(8): 701–7PubMedCrossRefGoogle Scholar
  41. 41.
    Pietrini D, Ciano F, Forte E, et al. Sevoflurane-remifentanil vs isoflurane-remifentanil for the surgical correction of craniosynostosis in infants. Paediatr Anaesth 2005; 15(8): 653–62PubMedCrossRefGoogle Scholar
  42. 42.
    Chambers N, Lopez T, Thomas J, et al. Remifentanil and the tunnelling phase of paediatric ventriculoperitoneal shunt insertion: a double-blind, randomised, prospective study. Anaesthesia 2002; 57(2): 133–9PubMedCrossRefGoogle Scholar
  43. 43.
    Sammartino M, Bocci MG, Ferro G, et al. Efficacy and safety of continuous intravenous infusion of remifentanil in preterm infants undergoing laser therapy in retinopathy of prematurity: clinical experience. Paediatr Anaesth 2003; 13(7): 596–602PubMedCrossRefGoogle Scholar
  44. 44.
    Guruswamy V, Roberts S, Arnold P, et al. Anaesthetic management of a neonate with congenital cyst adenoid malformation. Br J Anaesth 2005; 95(2): 240–2PubMedCrossRefGoogle Scholar
  45. 45.
    Koomen E, Poortmans G, Anderson BJ, et al. Jet ventilation for laryngotracheal surgery in an ex-premature infant. Paediatr Anaesth 2005; 15(9): 786–9PubMedCrossRefGoogle Scholar
  46. 46.
    Sommer M, Riedel J, Fusch C, et al. Intravenous anaesthesia with remifentanil in a preterm infant. Paediatr Anaesth 2001; 11(2): 252–4PubMedCrossRefGoogle Scholar
  47. 47.
    Tsiotou AG, Matsota P, Kouptsova E, et al. Use of remifentanil in an infant with surgically repaired Shone's syndrome. Paediatr Anaesth 2004; 14(3): 261–4PubMedCrossRefGoogle Scholar
  48. 48.
    Kessler P, Ahrens P, Lischke V, et al. Einsatz von Remifentanil bei Neugeborenen und Sauglingen. Anaesthesiologie und Intensivmedizin 1999, 40, Abstractband DAK 99Google Scholar
  49. 49.
    Foubert L, Reyntjens K, De Wolf D, et al. Remifentanil infusion for cardiac catheterization in children with congenital heart disease. Acta Anaesthesiol Scand 2002; 46(4): 355–60PubMedCrossRefGoogle Scholar
  50. 50.
    Reyntjens K, Foubert L, De Wolf D, et al. Glycopyrrolate during sevoflurane-remifentanil-based anaesthesia for cardiac catheterization of children with congenital heart disease. Br J Anaesth 2005; 95(5): 680–4PubMedCrossRefGoogle Scholar
  51. 51.
    Ansermino JM, Brooks P, Rosen D, et al. Spontaneous ventilation with remifentanil in children. Paediatr Anaesth 2005; 15(2): 115–21PubMedCrossRefGoogle Scholar
  52. 52.
    Antmen B, Sasmaz I, Birbicer H, et al. Safe and effective sedation and analgesia for bone marrow aspiration procedures in children with alfentanil, remifentanil and combinations with midazolam. Paediatr Anaesth 2005; 15(3): 214–9PubMedCrossRefGoogle Scholar
  53. 53.
    Berkenbosch JW, Graff GR, Stark JM, et al. Use of a remifentanil-propofol mixture for pediatric flexible fiberoptic bronchoscopy sedation. Paediatr Anaesth 2004; 14(11): 941–6PubMedCrossRefGoogle Scholar
  54. 54.
    Keidan I, Berkenstadt H, Sidi A, et al. Propofol/remifentanil versus propofol alone for bone marrow aspiration in paediatric haemato-oncological patients. Paediatr Anaesth 2001; 11(3): 297–301PubMedCrossRefGoogle Scholar
  55. 55.
    Litman RS. Conscious sedation with remifentanil and midazolam during brief painful procedures in children. Arch Pediatr Adolesc Med 1999; 153(10): 1085–8PubMedGoogle Scholar
  56. 56.
    Litman RS. Conscious sedation with remifentanil during painful medical procedures. J Pain Symptom Manage 2000; 19(6): 468–71PubMedCrossRefGoogle Scholar
  57. 57.
    Reyle-Hahn M, Niggemann B, Max M, et al. Remifentanil and propofol for sedation in children and young adolescents undergoing diagnostic flexible bronchoscopy. Paediatr Anaesth 2000; 10(1): 59–63PubMedCrossRefGoogle Scholar
  58. 58.
    Glaisyer HR, Sury MR. Recovery after anesthesia for short pediatric oncology procedures: propofol and remifentanil compared with propofol, nitrous oxide, and sevoflurane. Anesth Analg 2005; 100(4): 959–63PubMedCrossRefGoogle Scholar
  59. 59.
    Donmez A, Kizilkan A, Berksun H, et al. One center's experience with remifentanil infusions for pediatric cardiac catheterization. J Cardiothorac Vasc Anesth 2001; 15(6): 736–9PubMedCrossRefGoogle Scholar
  60. 60.
    Tsui BC, Wagner A, Usher AG, et al. Combined propofol and remifentanil intravenous anesthesia for pediatric patients undergoing magnetic resonance imaging. Paediatr Anaesth 2005; 15(5): 397–401PubMedCrossRefGoogle Scholar
  61. 61.
    Akinci SB, Kanbak M, Guler A, et al. Remifentanil versus fentanyl for short-term analgesia-based sedation in mechanically ventilated postoperative children. Paediatr Anaesth 2005; 15(10): 870–8PubMedCrossRefGoogle Scholar
  62. 62.
    German JW, Aneja R, Heard C, et al. Continuous remifentanil for pediatric neurosurgery patients. Pediatr Neurosurg 2000; 33(5): 227–9PubMedCrossRefGoogle Scholar
  63. 63.
    Stoppa F, Perrotta D, Tomasello C, et al. Low dose remifentanyl infusion for analgesia and sedation in ventilated newborns. Minerva Anestesiol 2004; 70(11): 753–61PubMedGoogle Scholar
  64. 64.
    Eck JB, Lynn AM. Use of remifentanil in infants. Paediatr Anaesth 1998; 8(5): 437–9PubMedCrossRefGoogle Scholar
  65. 65.
    Pereirae Silva Y, Gomez RS, Barbosa RF, et al. Remifentanil for sedation and analgesia in a preterm neonate with respiratory distress syndrome. Paediatr Anaesth 2005; 15(11): 993–6CrossRefGoogle Scholar
  66. 66.
    Crawford MW, Hayes J, Tan JM. Dose-response of remifentanil for tracheal intubation in infants. Anesth Analg 2005; 100(6): 1599–604PubMedCrossRefGoogle Scholar
  67. 67.
    Cavaliere F, Antonelli M, Arcangeli A, et al. A low-dose remifentanil infusion is well tolerated for sedation in mechanically ventilated, critically-ill patients. Can J Anaesth 2002; 49(10): 1088–94PubMedCrossRefGoogle Scholar
  68. 68.
    Adelmann CgM. Vergleich von Fentanyl und Sufentanil in der Analgo-Sedierung bei beatmeten reifen Neugeborenen mit Lungenversagen [Thesis/Dissertation]. Medizinische Fakultät der Universität zu Köln; 2004Google Scholar
  69. 69.
    Angst MS, Koppert W, Pahl I, et al. Short-term infusion of the mu-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal. Pain 2003; 106(1–2): 49–57PubMedCrossRefGoogle Scholar
  70. 70.
    Guignard B, Bossard AE, Coste C, et al. Acute opioid tolerance: intraoperative remifentanil increases postoperative pain and morphine requirement. Anesthesiology 2000; 93(2): 409–17PubMedCrossRefGoogle Scholar
  71. 71.
    Vinik HR, Kissin I. Rapid development of tolerance to analgesia during remifentanil infusion in humans. Anesth Analg 1998; 86(6): 1307–11PubMedGoogle Scholar
  72. 72.
    Cortinez LI, Brandes V, Munoz HR, et al. No clinical evidence of acute opioid tolerance after remifentanil-based anaesthesia. Br J Anaesth 2001; 87(6): 866–9PubMedCrossRefGoogle Scholar
  73. 73.
    Gustorff B, Nahlik G, Hoerauf KH, et al. The absence of acute tolerance during remifentanil infusion in volunteers. Anesth Analg 2002; 94(5): 1223–8PubMedCrossRefGoogle Scholar
  74. 74.
    Lee LH, Irwin MG, Lui SK. Intraoperative remifentanil infusion does not increase postoperative opioid consumption compared with 70% nitrous oxide. Anesthesiology 2005; 102(2): 398–402PubMedCrossRefGoogle Scholar
  75. 75.
    Minkowitz HS. Postoperative pain management in patients undergoing major surgery after remifentanil vs fentanyl anesthesia. Multicentre Investigator Group. Can J Anaesth 2000; 47(6): 522–8Google Scholar
  76. 76.
    Schraag S, Checketts MR, Kenny GN. Lack of rapid development of opioid tolerance during alfentanil and remifentanil infusions for postoperative pain. Anesth Analg 1999; 89(3): 753–7PubMedGoogle Scholar
  77. 77.
    Hahnenkamp K, Nollet J, Van Aken HK, et al. Remifentanil directly activates human N-methyl-D-aspartate receptors expressed in Xenopus laevis oocytes. Anesthesiology 2004; 100(6): 1531–7PubMedCrossRefGoogle Scholar
  78. 78.
    Koppert W. Opioid-induced hyperalgesia. Pathophysiology and clinical relevance [in German]. Anaesthesist 2004; 53(5): 455–66PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2006

Authors and Affiliations

  1. 1.Department of Neonatology and Pediatric Intensive CareUniversity of Cologne, Children's HospitalCologneGermany

Personalised recommendations